{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:29:25Z","timestamp":1778131765528,"version":"3.51.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jogc.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T16:15:19Z","timestamp":1463242519000},"page":"636-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Medications Used in Evidence-Based Regimens for Medical Abortion: An Overview"],"prefix":"10.1016","volume":"38","author":[{"given":"Judith A.","family":"Soon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dustin","family":"Costescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2016.04.005_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.contraception.2011.06.009","article-title":"Induced abortion in Canada 1974-2005: trends over the first generation with legal access","volume":"85","author":"Norman","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib2","unstructured":"Canadian Institute for Health Information. Number of Induced Abortions Reported in Canada in 2012, by Province\/Territory of Hospital or Clinic. Available at: https:\/\/www.cihi.ca\/sites\/default\/files\/document\/ta_11_alldatatables20140221_en.pdf. Accessed on April 14,\u00a02016."},{"key":"10.1016\/j.jogc.2016.04.005_bib3","first-page":"e209","article-title":"Abortion health services in Canada. Results of a 2012 national survey","volume":"62","author":"Norman","year":"2016","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jogc.2016.04.005_bib4","first-page":"e201","article-title":"First-trimester medical abortion practices in Canada. National survey","volume":"62","author":"Guilbert","year":"2016","journal-title":"Can Fam Physician"},{"issue":"5 Pt 1","key":"10.1016\/j.jogc.2016.04.005_bib5","first-page":"813","article-title":"Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol","volume":"99","author":"Wiebe","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijgo.2007.10.015","article-title":"Comparison of four regimens of misoprostol after methotrexate for early abortion","volume":"101","author":"Wiebe","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"issue":"11","key":"10.1016\/j.jogc.2016.04.005_bib7","first-page":"CD002855","article-title":"Medical methods for first trimester abortion","author":"Kulier","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2016.04.005_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/bmj.307.6903.532","article-title":"Termination of pregnancy with reduced doses of mifepristone","volume":"307","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2016.04.005_bib9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/AOG.0b013e3181b2a74d","article-title":"Effect of mifepristone on abortion access in the United States","volume":"114","author":"Finer","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib10","doi-asserted-by":"crossref","unstructured":"Costescu D, Guilbert E, Bernardin J, Black A, Dunn S, Fitzsimmons B, et\u00a0al. Medical abortion guidelines [e-pub ahead of print]. J Obstet Gynaecol Can, http:\/\/dx.doi.org\/10.1016\/j.jogc.2016.01.002. Accessed on April 14,\u00a02016.","DOI":"10.1016\/j.jogc.2016.01.002"},{"key":"10.1016\/j.jogc.2016.04.005_bib11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2165\/00003495-199345030-00007","article-title":"Mifepristone. A review of its pharmacodynamics and pharmacokinetic properties, and therapeutic potential","volume":"45","author":"Brogden","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.jogc.2016.04.005_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/jcem-59-1-25","article-title":"The new steroid analog RU 486 inhibits glucocorticoid action in man","volume":"59","author":"Bertagna","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jogc.2016.04.005_bib13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00003081-199606000-00017","article-title":"Mifepristone: Clinical pharmacology","volume":"39","author":"Robbins","year":"1996","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib14","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1056\/NEJMra000763","article-title":"Implantation and the survival of early pregnancy","volume":"345","author":"Norwitz","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2016.04.005_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00006254-197802000-00001","article-title":"Indispensability of the human corpus luteum in the maintenance of early pregnancy: luteectomy evidence","volume":"33","author":"Csapo","year":"1978","journal-title":"Obstet Gynecol Surv"},{"issue":"3 Suppl","key":"10.1016\/j.jogc.2016.04.005_bib16","first-page":"121","article-title":"Mode of action of medical methods of abortion","volume":"53","author":"Baird","year":"2000","journal-title":"J\u00a0Am Med Womens Assoc"},{"key":"10.1016\/j.jogc.2016.04.005_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1677\/joe.0.0850379","article-title":"Suppression of concentration of endometrial prostaglandin in early intra-uterine and ectopic pregnancy in women","volume":"85","author":"Abel","year":"1980","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.jogc.2016.04.005_bib18","first-page":"108","article-title":"Secretory component: a potential regulator of endometrial-decidual prostaglandin production in early human pregnancy","volume":"183","author":"Norwitz","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000298974","article-title":"Early ultrastructural changes in RU-486-exposed decidua","volume":"20","author":"Schindler","year":"1985","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jogc.2016.04.005_bib20","series-title":"The antiprogestin steroid RU 486 and human fertility control","first-page":"179","article-title":"Effects of the antiprogesterone RU 486 in early pregnancy and during the menstrual cycle","author":"Herrmann","year":"1985"},{"key":"10.1016\/j.jogc.2016.04.005_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1749-6632.1995.tb31380.x","article-title":"Mechanism of action of antiprogestins in the pregnant uterus","volume":"761","author":"Chwalisz","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jogc.2016.04.005_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.contraception.2015.03.004","article-title":"Early serum human chorionic gonadotropin (hCG) trends after medication abortion","volume":"91","author":"Pocius","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0010-7824(92)90066-3","article-title":"Cervical ripening with mifepristone (RU 486) after pretreatment with naproxen. A double-blind randomized study","volume":"4","author":"Radestad","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.contraception.2011.01.013","article-title":"Ovulation resumption after medical abortion with mifepristone and misoprostol","volume":"84","author":"Schreiber","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0010-7824(96)00116-3","article-title":"Determination of RU 486 (mifepristone) in blood by radioreceptor assay; a pharmacokinetic study","volume":"54","author":"Foldesi","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/07853899309147861","article-title":"Dose-response relationships of RU 486","volume":"25","author":"Heikinheimo","year":"1993","journal-title":"Ann Med"},{"key":"10.1016\/j.jogc.2016.04.005_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/oxfordjournals.humrep.a136554","article-title":"Metabolism and serum binding of RU 486 in women after various single doses","volume":"2","author":"Heikinheimo","year":"1987","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2016.04.005_bib28","first-page":"445","article-title":"In\u00a0vitro study of the binding of RU 486 and RU 42633 to human serum proteins","volume":"300","author":"Grimaldi","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.jogc.2016.04.005_bib29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0006-2952(96)00357-7","article-title":"Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes","volume":"52","author":"Jang","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jogc.2016.04.005_bib30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/00016341003721037","article-title":"Medical abortion in lactating women \u2013 low levels of mifepristone in breast milk","volume":"89","author":"Saav","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2016.04.005_bib31","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","article-title":"Drug metabolism","author":"Gonzalez","year":"2011"},{"key":"10.1016\/j.jogc.2016.04.005_bib32","unstructured":"Linepharma International Limited. Product monograph including patient medication information. Mifegymiso. https:\/\/www.cadth.ca\/sites\/default\/files\/cdr\/monograph\/mifegymiso_product_monograph.pdf. Accessed on April 17,\u00a02016."},{"key":"10.1016\/j.jogc.2016.04.005_bib33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2174\/138161208784139738","article-title":"Potential strategies for minimizing mechanism-based inhibition of cytochrome P450 3A4","volume":"14","author":"Zhou","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jogc.2016.04.005_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cbi.2012.05.007","article-title":"Assessment of drug-drug interactions caused by metabolism-dependent cytochrome P450 inhibition","volume":"198","author":"Lee","year":"2012","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jogc.2016.04.005_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.contraception.2015.06.001","article-title":"Continuing pregnancy after mifepristone and \u201creversal\u201d of first-trimester medical abortion: a systematic review","volume":"92","author":"Grossman","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/1471-0528.12147","article-title":"Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study","volume":"120","author":"Bernard","year":"2013","journal-title":"BJOG"},{"issue":"Suppl 2","key":"10.1016\/j.jogc.2016.04.005_bib37","first-page":"S160","article-title":"Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects","volume":"99","author":"Tang","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"issue":"11 Suppl","key":"10.1016\/j.jogc.2016.04.005_bib38","doi-asserted-by":"crossref","first-page":"114S","DOI":"10.1007\/BF01309395","article-title":"Chemistry and synthetic development of misoprostol","volume":"30","author":"Collins","year":"1985","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jogc.2016.04.005_bib39","doi-asserted-by":"crossref","first-page":"e112401","DOI":"10.1371\/journal.pone.0112401","article-title":"Instability of misoprostol tablets stored outside the blister: a potential serious concern for clinical outcome in medical abortion","volume":"9","author":"Berard","year":"2014","journal-title":"PLoS One"},{"issue":"3 Pt 1","key":"10.1016\/j.jogc.2016.04.005_bib40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.AOG.0000230398.32794.9d","article-title":"Misoprostol administered by epithelial routes: drug absorption and uterine response","volume":"108","author":"Meckstroth","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.contraception.2005.02.012","article-title":"The effect of orally and vaginally administrated misoprostol on inflammatory mediators and cervical ripening during early pregnancy","volume":"72","author":"Aronsson","year":"2005","journal-title":"Contraception"},{"issue":"2\u00a0Suppl","key":"10.1016\/j.jogc.2016.04.005_bib42","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1067\/mob.2000.107946","article-title":"Management of side effects and complications in medical abortion","volume":"183","author":"Kruse","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"11 Suppl","key":"10.1016\/j.jogc.2016.04.005_bib43","doi-asserted-by":"crossref","first-page":"126S","DOI":"10.1007\/BF01309397","article-title":"Metabolism and pharmacokinetic studies of misoprostol","volume":"30","author":"Schoenhard","year":"1985","journal-title":"Dig Dis Sci"},{"issue":"Suppl","key":"10.1016\/j.jogc.2016.04.005_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0090-6980(87)90047-5","article-title":"Antiulcer prostaglandin misoprostol: single and multiple dose pharmacokinetic profile","volume":"33","author":"Karim","year":"1987","journal-title":"Prostaglandins"},{"key":"10.1016\/j.jogc.2016.04.005_bib45","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/j.1552-4604.1995.tb04078.x","article-title":"Disposition of misoprostol and its active metabolite in patients with normal and impaired renal function","volume":"35","author":"Foote","year":"1995","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jogc.2016.04.005_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0029-7844(97)00111-7","article-title":"Absorption kinetics of misoprostol with oral or vaginal administration","volume":"90","author":"Zieman","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib47","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2016.04.005_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0301-2115(02)00355-X","article-title":"The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration","volume":"108","author":"Abdel-Aleem","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogc.2016.04.005_bib49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1056\/NEJM200101043440107","article-title":"Misoprostol and pregnancy","volume":"334","author":"Goldberg","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2016.04.005_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0140-6736(91)90046-R","article-title":"Misoprostol and congenital malformations","volume":"338","author":"Fonseca","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2016.04.005_bib51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.1320470113","article-title":"Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy","volume":"47","author":"Gonzalez","year":"1993","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jogc.2016.04.005_bib52","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/bdra.10144","article-title":"Mobius sequence in children exposed in utero to misoprostol: neuropathological study of three cases","volume":"67","author":"Marques-Dias","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.jogc.2016.04.005_bib53","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJM199806253382604","article-title":"Use of misoprostol during pregnancy and Mobius' syndrome in infants","volume":"338","author":"Pastuszak","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2016.04.005_bib54","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1345\/aph.1K550","article-title":"Mobius syndrome in a neonate after mifepristone and misoprostol elective abortion failure","volume":"42","author":"Bos-Thompson","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jogc.2016.04.005_bib55","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0033-1363466","article-title":"Mobius syndrome: misoprostol use and speech and language characteristics","volume":"18","author":"Guedes","year":"2014","journal-title":"Int Arch Otorhinolaryngol"},{"key":"10.1016\/j.jogc.2016.04.005_bib56","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","article-title":"Cytotoxic agents","author":"Chabner","year":"2011"},{"key":"10.1016\/j.jogc.2016.04.005_bib57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0010-7824(99)00031-1","article-title":"Tamoxifen compared to methotrexate when used with misoprostol for abortion","volume":"59","author":"Wiebe","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib58","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/humrep\/13.4.1063","article-title":"Effects of methotrexate on trophoblast proliferation and local immune responses","volume":"13","author":"DeLoia","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2016.04.005_bib59","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/0002-9378(90)90928-Z","article-title":"Reproductive performance after methotrexate treatment of ectopic pregnancy","volume":"162","author":"Stovall","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0002-9378(99)70451-5","article-title":"Oral methotrexate compared with injected methotrexate when used with misoprostol for abortion","volume":"181","author":"Wiebe","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib61","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/art.1780350603","article-title":"Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis","volume":"35","author":"Oguey","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jogc.2016.04.005_bib62","first-page":"1845","article-title":"A\u00a0comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing","volume":"20","author":"Jundt","year":"1993","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jogc.2016.04.005_bib63","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0002-9378(97)70089-9","article-title":"Methotrexate pharmacokinetics and effects in women receiving methotrexate 50 mg and 60 mg per square meter for early abortion","volume":"177","author":"Creinin","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib64","unstructured":"Pfizer Canada. Product Monograph. Methotrexate. Available at: http:\/\/www.pfizer.ca\/sites\/g\/files\/g10028126\/f\/201511\/Methotrexate_PM_E.pdf. Accessed on April 14,\u00a02016."},{"key":"10.1016\/j.jogc.2016.04.005_bib65","first-page":"494","article-title":"Methotrexate use in a lactating woman with an ectopic pregnancy","volume":"85","author":"Tanaka","year":"2009","journal-title":"Birth Defects Res Clin Mol Teratol"},{"key":"10.1016\/j.jogc.2016.04.005_bib66","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0002-9378(72)90824-1","article-title":"Secretion of methotrexate into human milk","volume":"112","author":"Johns","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib67","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1634\/theoncologist.2011-0431","article-title":"Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors","volume":"17","author":"Bezabeh","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.jogc.2016.04.005_bib68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/tera.10052","article-title":"Fetal methotrexate and misoprostol exposure: the past revisited","volume":"66","author":"Wheeler","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.jogc.2016.04.005_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bdra.23003","article-title":"Teratogen update: methotrexate","volume":"94","author":"Hyoun","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.jogc.2016.04.005_bib70","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijgo.2013.03.026","article-title":"New anomalies due to methotrexate and misoprostol exposure in early pregnancy","volume":"122","author":"MacDonald","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogc.2016.04.005_bib71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0010-7824(97)00021-8","article-title":"Abortion induced with methotrexate and misoprostol: a comparison of various protocols","volume":"55","author":"Wiebe","year":"1997","journal-title":"Contraception"},{"issue":"5 Pt 2","key":"10.1016\/j.jogc.2016.04.005_bib72","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/01.AOG.0000154002.26761.41","article-title":"Anomalies associated with failed methotrexate and misoprostol termination","volume":"105","author":"Yedlinsky","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib73","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.38368","article-title":"Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study","volume":"66","author":"Weber-Schoendorfer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jogc.2016.04.005_bib74","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/humrep\/16.10.2098","article-title":"Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation","volume":"16","author":"Bartley","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2016.04.005_bib75","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/oxfordjournals.humrep.a136973","article-title":"Termination of early human pregnancy with RU 486 (mifepristone) and the prostaglandin analogue sulprostone: a multi-centre, randomized comparison between two treatment regimens","volume":"4","author":"Bahzad","year":"1989","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2016.04.005_bib76","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0140-6736(91)91593-J","article-title":"Anonymous. A death associated with mifepristone\/sulprostone","volume":"337","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2016.04.005_bib77","series-title":"Holland-Frei Cancer Medicine","article-title":"Agents for chemoprevention and their mechanism of action","author":"Sporn","year":"2003"},{"key":"10.1016\/j.jogc.2016.04.005_bib78","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0010-7824(99)00105-5","article-title":"A\u00a0Comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination","volume":"6","author":"Jain","year":"1999","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.jogc.2016.04.005_bib79","first-page":"CD003370","article-title":"Aromatase inhibitors for treatment of advanced breast cancer in post-menopausal women","author":"Gibson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2016.04.005_bib80","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1472-6483(10)61046-2","article-title":"Randomized controlled trial of three doses of letrozole for ovulation induction in patients with unexplained infertility","volume":"14","author":"Badawy","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jogc.2016.04.005_bib81","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.contraception.2010.05.014","article-title":"A\u00a0pilot study on the use of letrozole with either misoprostol or mifepristone for termination of pregnancy up to 63 days","volume":"83","author":"Lee","year":"2011","journal-title":"Contraception"},{"issue":"2 Pt 1","key":"10.1016\/j.jogc.2016.04.005_bib82","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/AOG.0b013e3182073fbf","article-title":"Misoprostol with or without letrozole pretreatment for termination of pregnancy: a randomized trial","volume":"117","author":"Lee","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib83","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.contraception.2012.05.009","article-title":"A\u00a0pilot study on the use of a 7-day course of letrozole followed by misoprostol for the termination of early pregnancy up to 63 days","volume":"86","author":"Yeung","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib84","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.fertnstert.2004.01.006","article-title":"Aromatase inhibitors and teratogenesis","volume":"81","author":"Tiboni","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2016.04.005_bib85","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000357321","article-title":"Safety of tamoxifen during pregnancy: 3 case reports and review of the literature","volume":"8","author":"Koca","year":"2013","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.jogc.2016.04.005_bib86","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2016.04.005_bib87","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199504133321502","article-title":"Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol","volume":"332","author":"El-Rafaey","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2016.04.005_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(98)00150-4","article-title":"Low dose mifepristone 200 mg and vaginal misoprostol for abortion","volume":"59","author":"Schaff","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib89","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0010-7824(94)90010-8","article-title":"Methotrexate and misoprostol for abortion at 57\u201363 days' gestation","volume":"50","author":"Creinin","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib90","first-page":"754","article-title":"Single-dose methotrexate for treatment of ectopic pregnancy","volume":"77","author":"Stovall","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib91","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.fertnstert.2006.06.054","article-title":"Use of \u201c2-dose\u201d regimen of methotrexate to treat ectopic pregnancy","volume":"87","author":"Barnhart","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2016.04.005_bib92","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/AOG.0000000000001274","article-title":"Effect of immediate compared with delayed insertion of etonogestrel implants on medical abortion efficacy and repeat pregnancy: a randomized controlled trial","volume":"127","author":"Raymond","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.04.005_bib93","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.srhc.2010.02.002","article-title":"The contraceptive implant for long acting reversible contraception in patients undergoing first trimester medical termination of pregnancy","volume":"1","author":"Church","year":"2010","journal-title":"Sex Reprod Healthc"},{"key":"10.1016\/j.jogc.2016.04.005_bib94","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.contraception.2014.10.010","article-title":"Administration of depot medroxyprogesterone acetate on the day of mifepristone for medical abortion: a pilot study","volume":"91","author":"Sonalkar","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib95","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0010-7824(78)90046-X","article-title":"A\u00a0radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids","volume":"78","author":"Stanczyk","year":"1978","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2016.04.005_bib96","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1016\/S0010-7824(98)00120-6","article-title":"Pharmacokinetics of Implanon. An integrated analysis","volume":"58","author":"Huber","year":"1998","journal-title":"Contraception"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216316391046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216316391046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:28:01Z","timestamp":1761665281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216316391046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":96,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1701216316391046"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2016.04.005","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medications Used in Evidence-Based Regimens for Medical Abortion: An Overview","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada","name":"copyright","label":"Copyright"}]}}